Cargando…

‘I Don't Like Uncertainty, I Like to Know’: How and why uveal melanoma patients consent to life expectancy prognostication

BACKGROUND: Technological advances have led to cancer prognostication that is increasingly accurate but often unalterable. However, a reliable prognosis of limited life expectancy can cause psychological distress. People should carefully consider offers of prognostication, but little is known about...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Stephen L., Fisher, Peter L., Morgan, Andrew, Davies, Cari, Olabi, Yasmin, Hope‐Stone, Laura, Heimann, Heinrich, Hussain, Rumana, Cherry, Mary Gemma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327814/
https://www.ncbi.nlm.nih.gov/pubmed/35474381
http://dx.doi.org/10.1111/hex.13490
_version_ 1784757581638533120
author Brown, Stephen L.
Fisher, Peter L.
Morgan, Andrew
Davies, Cari
Olabi, Yasmin
Hope‐Stone, Laura
Heimann, Heinrich
Hussain, Rumana
Cherry, Mary Gemma
author_facet Brown, Stephen L.
Fisher, Peter L.
Morgan, Andrew
Davies, Cari
Olabi, Yasmin
Hope‐Stone, Laura
Heimann, Heinrich
Hussain, Rumana
Cherry, Mary Gemma
author_sort Brown, Stephen L.
collection PubMed
description BACKGROUND: Technological advances have led to cancer prognostication that is increasingly accurate but often unalterable. However, a reliable prognosis of limited life expectancy can cause psychological distress. People should carefully consider offers of prognostication, but little is known about how and why they decide on prognostication. Using uveal melanoma (UM) patients, we aimed to identify (i) how and why do people with UM decide to accept prognostication and (ii) alignment and divergence of their decision‐making from conceptualizations of a ‘well‐considered’ decision. METHODS: UM provides a paradigm to elucidate clinical and ethical perspectives on prognostication, because prognostication is reliable but prognoses are largely nonameliorable. We used qualitative methods to examine how and why 20 UM people with UM chose prognostication. We compared findings to a template of ‘well‐considered’ decision‐making, where ‘well‐considered’ decisions involve consideration of all likely outcomes. RESULTS: Participants wanted prognostication to reduce future worry about uncertain life expectancy. They spontaneously spoke of hoping for a good prognosis when making their decisions, but largely did not consider the 50% possibility of a poor prognosis. When pressed, they argued that a poor outcome at least brings certainty. CONCLUSIONS: While respecting decisions as valid expressions of participants' wishes, we are concerned that they did not explicitly consider the realistic possibility of a poor outcome and how this would affect them. Thus, it is difficult to see their decisions as ‘well‐considered’. We propose that nondirective preference exploration techniques could help people to consider the possibility of a poor outcome. PATIENT OR PUBLIC CONTRIBUTION: This paper is a direct response to a patient‐identified and defined problem that arose in therapeutic and conversational discourse. The research was informed by the responses of patient participants, as we used the material from interviews to dynamically shape the interview guide. Thus, participants' ideas drove the analysis and shaped the interviews to come.
format Online
Article
Text
id pubmed-9327814
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93278142022-08-01 ‘I Don't Like Uncertainty, I Like to Know’: How and why uveal melanoma patients consent to life expectancy prognostication Brown, Stephen L. Fisher, Peter L. Morgan, Andrew Davies, Cari Olabi, Yasmin Hope‐Stone, Laura Heimann, Heinrich Hussain, Rumana Cherry, Mary Gemma Health Expect Original Articles BACKGROUND: Technological advances have led to cancer prognostication that is increasingly accurate but often unalterable. However, a reliable prognosis of limited life expectancy can cause psychological distress. People should carefully consider offers of prognostication, but little is known about how and why they decide on prognostication. Using uveal melanoma (UM) patients, we aimed to identify (i) how and why do people with UM decide to accept prognostication and (ii) alignment and divergence of their decision‐making from conceptualizations of a ‘well‐considered’ decision. METHODS: UM provides a paradigm to elucidate clinical and ethical perspectives on prognostication, because prognostication is reliable but prognoses are largely nonameliorable. We used qualitative methods to examine how and why 20 UM people with UM chose prognostication. We compared findings to a template of ‘well‐considered’ decision‐making, where ‘well‐considered’ decisions involve consideration of all likely outcomes. RESULTS: Participants wanted prognostication to reduce future worry about uncertain life expectancy. They spontaneously spoke of hoping for a good prognosis when making their decisions, but largely did not consider the 50% possibility of a poor prognosis. When pressed, they argued that a poor outcome at least brings certainty. CONCLUSIONS: While respecting decisions as valid expressions of participants' wishes, we are concerned that they did not explicitly consider the realistic possibility of a poor outcome and how this would affect them. Thus, it is difficult to see their decisions as ‘well‐considered’. We propose that nondirective preference exploration techniques could help people to consider the possibility of a poor outcome. PATIENT OR PUBLIC CONTRIBUTION: This paper is a direct response to a patient‐identified and defined problem that arose in therapeutic and conversational discourse. The research was informed by the responses of patient participants, as we used the material from interviews to dynamically shape the interview guide. Thus, participants' ideas drove the analysis and shaped the interviews to come. John Wiley and Sons Inc. 2022-04-26 2022-08 /pmc/articles/PMC9327814/ /pubmed/35474381 http://dx.doi.org/10.1111/hex.13490 Text en © 2022 The Authors. Health Expectations published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Brown, Stephen L.
Fisher, Peter L.
Morgan, Andrew
Davies, Cari
Olabi, Yasmin
Hope‐Stone, Laura
Heimann, Heinrich
Hussain, Rumana
Cherry, Mary Gemma
‘I Don't Like Uncertainty, I Like to Know’: How and why uveal melanoma patients consent to life expectancy prognostication
title ‘I Don't Like Uncertainty, I Like to Know’: How and why uveal melanoma patients consent to life expectancy prognostication
title_full ‘I Don't Like Uncertainty, I Like to Know’: How and why uveal melanoma patients consent to life expectancy prognostication
title_fullStr ‘I Don't Like Uncertainty, I Like to Know’: How and why uveal melanoma patients consent to life expectancy prognostication
title_full_unstemmed ‘I Don't Like Uncertainty, I Like to Know’: How and why uveal melanoma patients consent to life expectancy prognostication
title_short ‘I Don't Like Uncertainty, I Like to Know’: How and why uveal melanoma patients consent to life expectancy prognostication
title_sort ‘i don't like uncertainty, i like to know’: how and why uveal melanoma patients consent to life expectancy prognostication
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327814/
https://www.ncbi.nlm.nih.gov/pubmed/35474381
http://dx.doi.org/10.1111/hex.13490
work_keys_str_mv AT brownstephenl idontlikeuncertaintyiliketoknowhowandwhyuvealmelanomapatientsconsenttolifeexpectancyprognostication
AT fisherpeterl idontlikeuncertaintyiliketoknowhowandwhyuvealmelanomapatientsconsenttolifeexpectancyprognostication
AT morganandrew idontlikeuncertaintyiliketoknowhowandwhyuvealmelanomapatientsconsenttolifeexpectancyprognostication
AT daviescari idontlikeuncertaintyiliketoknowhowandwhyuvealmelanomapatientsconsenttolifeexpectancyprognostication
AT olabiyasmin idontlikeuncertaintyiliketoknowhowandwhyuvealmelanomapatientsconsenttolifeexpectancyprognostication
AT hopestonelaura idontlikeuncertaintyiliketoknowhowandwhyuvealmelanomapatientsconsenttolifeexpectancyprognostication
AT heimannheinrich idontlikeuncertaintyiliketoknowhowandwhyuvealmelanomapatientsconsenttolifeexpectancyprognostication
AT hussainrumana idontlikeuncertaintyiliketoknowhowandwhyuvealmelanomapatientsconsenttolifeexpectancyprognostication
AT cherrymarygemma idontlikeuncertaintyiliketoknowhowandwhyuvealmelanomapatientsconsenttolifeexpectancyprognostication